{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T13:10:18Z","timestamp":1782306618048,"version":"3.54.5"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP256f0137006"],"award-info":[{"award-number":["JP256f0137006"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["020-0081"],"award-info":[{"award-number":["020-0081"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.labinv.2025.106070","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T07:38:58Z","timestamp":1767685138000},"page":"106070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic Potential of Tn-MUC1 in Breast Cancer: A Novel Immunohistochemical Marker Reflecting Tumor Progression"],"prefix":"10.1016","volume":"106","author":[{"given":"Ai","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako C.","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayae","family":"Nange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asami","family":"Okumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Takehashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0489-535X","authenticated-orcid":false,"given":"Yoshiki","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Naruchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3128-1477","authenticated-orcid":false,"given":"Yutaka","family":"Hatanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Matsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.labinv.2025.106070_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0046-8177(95)90146-9","article-title":"Prognostic significance of MUC1 epithelial mucin expression in breast cancer","volume":"26","author":"McGuckin","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1016\/j.labinv.2025.106070_bib2","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0304-4157(95)00014-3","article-title":"The epithelial mucin MUC1 of milk, mammary gland and other tissues","volume":"1241","author":"Patton","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.labinv.2025.106070_bib3","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/bcr1515","article-title":"MUC1 alters oncogenic events and transcription in human breast cancer cells","volume":"8","author":"Hattrup","year":"2006","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.labinv.2025.106070_bib4","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","article-title":"MUC1: a multifaceted oncoprotein with a key role in cancer progression","volume":"20","author":"Nath","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.labinv.2025.106070_bib5","doi-asserted-by":"crossref","first-page":"33325","DOI":"10.1074\/jbc.271.52.33325","article-title":"Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells","volume":"271","author":"Lloyd","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.labinv.2025.106070_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/tan.12900","article-title":"Tumor-associated antigens: Tn antigen, STn antigen, and T antigen","volume":"88","author":"Fu","year":"2016","journal-title":"HLA"},{"key":"10.1016\/j.labinv.2025.106070_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molonc.2009.12.001","article-title":"Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression","volume":"4","author":"Potapenko","year":"2010","journal-title":"Mol Oncol"},{"key":"10.1016\/j.labinv.2025.106070_bib8","doi-asserted-by":"crossref","first-page":"18165","DOI":"10.1074\/jbc.274.26.18165","article-title":"High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells","volume":"274","author":"M\u00fcller","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.labinv.2025.106070_bib9","doi-asserted-by":"crossref","first-page":"15099","DOI":"10.1016\/S0021-9258(18)98592-3","article-title":"Molecular cloning and analysis of the mouse homologue of the tumor-associated mucin, MUC1, reveals conservation of potential O-glycosylation sites, transmembrane, and cytoplasmic domains and a loss of minisatellite-like polymorphism","volume":"266","author":"Spicer","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.labinv.2025.106070_bib10","doi-asserted-by":"crossref","first-page":"16613","DOI":"10.1073\/pnas.262438199","article-title":"A unique molecular chaperone Cosmc required for activity of the mammalian core 1 \u03b23-galactosyltransferase","volume":"99","author":"Ju","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.labinv.2025.106070_bib11","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/anie.201002313","article-title":"The Tn antigen-structural simplicity and biological complexity","volume":"50","author":"Ju","year":"2011","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.labinv.2025.106070_bib12","first-page":"4361","article-title":"Immunoglobulin G3 monoclonal antibody directed to Tn antigen (tumor-associated alpha-N-acetylgalactosaminyl epitope) that does not cross-react with blood group A antigen","volume":"48","author":"Takahashi","year":"1988","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2025.106070_bib13","first-page":"587","article-title":"Pancarcinoma T and Tn epitopes: autoimmunogens and diagnostic markers that reveal incipient carcinomas and help establish prognosis","volume":"53","author":"Springer","year":"1990","journal-title":"Immunol Ser"},{"key":"10.1016\/j.labinv.2025.106070_bib14","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0006-291X(90)90488-9","article-title":"A monoclonal antibody directed to Tn antigen","volume":"170","author":"Numata","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.labinv.2025.106070_bib15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1537-2995.1991.31291142945.x","article-title":"Immunochemical studies on the differential binding properties of two monoclonal antibodies reacting with Tn red cells","volume":"31","author":"King","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.labinv.2025.106070_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0165-2478(93)90095-J","article-title":"Use of O-glycosylation-defective human lymphoid cell lines and flow cytometry to delineate the specificity of Moluccella laevis lectin and monoclonal antibody 5F4 for the Tn antigen (GalNAc alpha 1-O-Ser\/Thr)","volume":"36","author":"Thurnher","year":"1993","journal-title":"Immunol Lett"},{"key":"10.1016\/j.labinv.2025.106070_bib17","first-page":"2229","article-title":"Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells","volume":"56","author":"Terasawa","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2025.106070_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0014-5793(00)01248-5","article-title":"Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy","volume":"469","author":"Osinaga","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.labinv.2025.106070_bib19","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1432-1033.2002.02787.x","article-title":"NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3","volume":"269","author":"M\u00f6ller","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.labinv.2025.106070_bib20","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1126\/science.1129200","article-title":"A mutant chaperone converts a wild-type protein into a tumor-specific antigen","volume":"314","author":"Schietinger","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.labinv.2025.106070_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00262-006-0135-9","article-title":"PankoMab: a potent new generation anti-tumour MUC1 antibody","volume":"55","author":"Danielczyk","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.labinv.2025.106070_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/glycob\/cwl061","article-title":"Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat","volume":"17","author":"Tarp","year":"2007","journal-title":"Glycobiology"},{"key":"10.1016\/j.labinv.2025.106070_bib23","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1248\/bpb.31.1739","article-title":"Mouse-human chimeric anti-Tn IgG1 induced anti-tumor activity against Jurkat cells in vitro and in vivo","volume":"31","author":"Ando","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.labinv.2025.106070_bib24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/glycob\/cwp085","article-title":"A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell\u2013lymphatic endothelium interaction","volume":"19","author":"Danussi","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.labinv.2025.106070_bib25","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/glycob\/cwr048","article-title":"A new murine IgG1 anti-Tn monoclonal antibody with in vivo anti-tumor activity","volume":"21","author":"Welinder","year":"2011","journal-title":"Glycobiology"},{"key":"10.1016\/j.labinv.2025.106070_bib26","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00262-018-2206-0","article-title":"Production of a mouse monoclonal IgM antibody that targets the carbohydrate Thomsen\u2013nouveau cancer antigen resulting in in vivo and in vitro tumor killing","volume":"67","author":"Trabbic","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.labinv.2025.106070_bib27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/glycob\/cwz004","article-title":"A strategy for generating cancer-specific monoclonal antibodies to aberrant O-glycoproteins: identification of a novel dysadherin-Tn antibody","volume":"29","author":"Steentoft","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.labinv.2025.106070_bib28","first-page":"282","article-title":"Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies","volume":"30","author":"Matsumoto","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.labinv.2025.106070_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejca.2016.05.003","article-title":"A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas","volume":"63","author":"Fiedler","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.labinv.2025.106070_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx440.035","article-title":"A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX after chemotherapy in patients with recurrent epithelial ovarian carcinoma","volume":"28","author":"Ledermann","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.labinv.2025.106070_bib31","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.2021.39.15_suppl.2522","article-title":"Activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients with refractory solid tumors","volume":"39","author":"Garralda","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.labinv.2025.106070_bib32","doi-asserted-by":"crossref","first-page":"6579","DOI":"10.1158\/1538-7445.AM2024-6579","article-title":"Abstract 6579: DS-3939a, a novel TA-MUC1-targeting antibody-drug conjugate (ADC) with a DNA topoisomerase I inhibitor DXd, exhibits potent antitumor activity in preclinical models","volume":"84","author":"Yukiura","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.labinv.2025.106070_bib33","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.16_suppl.TPS3165","article-title":"A phase 1\/2, first-in-human study of DS-3939a in patients with advanced solid tumors: a new DXd ADC targeting TA-MUC1","volume":"42","author":"Yamamoto","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.labinv.2025.106070_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00262-020-02503-0","article-title":"The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients","volume":"69","author":"Rosenbaum","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"Suppl 1","key":"10.1016\/j.labinv.2025.106070_bib35","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000056504","article-title":"Epitope characterization of MUC1 antibodies","volume":"19","author":"Blockzjil","year":"1998","journal-title":"Tumour Biol"},{"key":"10.1016\/j.labinv.2025.106070_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.bbagen.2013.11.009","article-title":"A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides","volume":"1840","author":"Matsushita","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.labinv.2025.106070_bib37","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13046-015-0152-7","article-title":"Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX\u2122 is an independent prognostic marker for breast cancer patients","volume":"34","author":"Heublein","year":"2015","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.labinv.2025.106070_bib38","doi-asserted-by":"crossref","first-page":"7493","DOI":"10.1021\/acsomega.7b00708","article-title":"Generation of novel anti-MUC1 monoclonal antibodies with designed carbohydrate specificities using MUC1 glycopeptide library","volume":"2","author":"Naito","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.labinv.2025.106070_bib39","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3892\/ol.2021.12463","article-title":"A novel Tn antigen epitope-recognizing antibody for MUC1 predicts clinical outcome in patients with primary lung adenocarcinoma","volume":"21","author":"Kato","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.labinv.2025.106070_bib40","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/bjc.1995.199","article-title":"Expression of \u03b1-GalNAc glycoproteins by breast cancers","volume":"71","author":"Brooks","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.labinv.2025.106070_bib41","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s41416-021-01530-7","article-title":"Mapping of truncated O-glycans in cancers of epithelial and non-epithelial origin","volume":"125","author":"R\u00f8mer","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1016\/j.labinv.2025.106070_bib42","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00262-013-1425-7","article-title":"Monoclonal antibodies toward different Tn-amino acid backbones display distinct recognition patterns on human cancer cells. Implications for effective immuno-targeting of cancer","volume":"62","author":"Mazal","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.labinv.2025.106070_bib43","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1023\/A:1011379725811","article-title":"MUC1, the renaissance molecule","volume":"6","author":"Gendler","year":"2001","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.labinv.2025.106070_bib44","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1091\/mbc.11.3.819","article-title":"Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state","volume":"11","author":"Altschuler","year":"2000","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.labinv.2025.106070_bib45","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215815120","article-title":"Steric pressure between glycosylated transmembrane proteins inhibits internalization by endocytosis","volume":"120","author":"Gollapudi","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.labinv.2025.106070_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clbc.2012.09.016","article-title":"Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues","volume":"13","author":"Ghosh","year":"2013","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.labinv.2025.106070_bib47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/modpathol.3800445","article-title":"Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer","volume":"18","author":"Rakha","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.labinv.2025.106070_bib48","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1053\/j.gastro.2018.08.007","article-title":"Disruption of C1GALT1 gene promotes development and metastasis of pancreatic adenocarcinomas in mice","volume":"155","author":"Chugh","year":"2018","journal-title":"Gastroenterology"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725019816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725019816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:27:03Z","timestamp":1781767623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725019816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0023683725019816"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.106070","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Potential of Tn-MUC1 in Breast Cancer: A Novel Immunohistochemical Marker Reflecting Tumor Progression","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.106070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106070"}}